Table 1. The effects of exam period on measures of somatic symptoms and stress: Descriptive results.
| Pre-baseline | Exam period | Post-baseline | |
|---|---|---|---|
| n=141 | n=123 | n=118 | |
| Mean±SD | |||
| Primary variable: | |||
| SOMS-7d | 11.1±8.9 | 18.2±14.5 | 9.7±9.0 |
| Control variables: | |||
| PSQ-20 | 33.6±17.5 | 54.0±19.3 | 29.8±18.3 |
| BDI-II | 6.6±6.4 | 11.5±7.0 | 5.2±5.4 |
| STAI-G-X1 state | 36.9±8.1 | 42.74±12.3 | 37.1±10.3 |
| Side aim: Temporal stability of the TAS-20 | |||
| TAS-20 | 45.3±9.7 | 45.9±10.1 | 44.6±10.2 |
Abbreviations: BDI-II: Beck’s Depression Inventory; PSQ-20: Perceived Stress Questionnaire; SOMS-7d: Screening for Somatoform Symptoms 7-day version; STAI-G-X1 state: State-Trait Anxiety Inventory – State Form; TAS-20: Toronto Alexithymia Scale 20-item version.